Europos Sąjunga - danų - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Danija - danų - Lægemiddelstyrelsen (Danish Medicines Agency)

hexal a/s - dimethylfumarat - enterokapsler, hårde - 120 mg

Danija - danų - Lægemiddelstyrelsen (Danish Medicines Agency)

hexal a/s - dimethylfumarat - enterokapsler, hårde - 240 mg

Europos Sąjunga - danų - EMA (European Medicines Agency)

pfizer europe ma eeig - neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid - meningitis, meningokok - vacciner - nimenrix er indiceret til aktiv immunisering af personer fra 6 uger mod invasive meningokoksygdomme forårsaget af neisseria meningitidis gruppe a, c, w-135 og y.

Danija - danų - Lægemiddelstyrelsen (Danish Medicines Agency)

gsk vaccines s.r.l. - corynebacterium diphtheriae crm-197 protein, neisseria meningitidis serogroup c, stamme c11, oligosaccharid - injektionsvæske, suspension, fyldt injektionssprøjte - 10 mikrogram

Danija - danų - Lægemiddelstyrelsen (Danish Medicines Agency)

gsk vaccines s.r.l. - corynebacterium diphtheriae crm-197 protein, neisseria meningitidis serogroup c, stamme c11, oligosaccharid - injektionsvæske, suspension, hætteglas - 10 mikrogram

Danija - danų - Lægemiddelstyrelsen (Danish Medicines Agency)

pfizer aps - clostridium tetani, toxoid, neisseria meningitidis polysaccharid serogruppe c, stamme c11, de-o-acetyleret - injektionsvæske, suspension, fyldt injektionssprøjte - 10 mikrogram/dosis

Europos Sąjunga - danų - EMA (European Medicines Agency)

sanofi pasteur - neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid - meningitis, meningokok - vacciner - menquadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, w, and y. the use of this vaccine should be in accordance with available official recommendations.